Journal: Bioscience Reports
Article Title: 17β-estradiol binding to ERα promotes the progression of prolactinoma through estrogen-response element-induced CaBP-9k up-regulation
doi: 10.1042/BSR20191330
Figure Lengend Snippet: ( A,B ) MMQ and GH3 cells were treated with 0, 0.1, 1 and 10 nmol/l E2 for 24 h, then the cells were collected and submitted to (A,B) Western blotting assay to test the protein expression levels of CaBP-9k, ERα and ERβ (* P <0.05). ( C,D ) GH3 and MMQ cells were treated with 300 nM AZD9496 for 1 h prior to 1 nM E2 treatment, then the cells were harvested and subjected to Western blotting to test the protein expressions of CaBP-9k, ERα and ERβ (* ,+ P <0.05, compared with NC group; # P<0.05, compared with E2 group).
Article Snippet: Next, the membrane was blocked with 5% non–fat milk for 1 h at room temperature, and incubated with the primary antibodies CaBP-9k (No. sc-74462, Santa Cruz, CA, U.S.A.), ERα (No. ab32063, Abcam, MA, U.S.A.), ERβ (No. sc-53494, Santa Cruz) or GAPDH (Proteintech, Hubei, China) overnight at 4°C.
Techniques: Western Blot, Expressing